Showing results (1141-1150 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|March 5, 2016
Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma ModelsElizabeth A Punnoose, Joel D Leverson, Franklin Peale, et al.
Molecular Cancer Therapeutics|March 5, 2016
Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival SignalingLászló G Puskás, Imola Mán, Gabor Szebeni, et al.
Molecular Cancer Therapeutics|August 13, 2015
Durability of Kinase-Directed Therapies--A Network Perspective on Response and ResistanceBrion W Murray, Nichol Miller
Molecular Cancer Therapeutics|August 13, 2015
Sphingosine Kinase-1 Protects Multiple Myeloma from Apoptosis Driven by Cancer-Specific Inhibition of RTKsShuntaro Tsukamoto, Yuhui Huang, Motofumi Kumazoe, et al.
Molecular Cancer Therapeutics|September 4, 2015
A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or LymphomaRavi K Amaravadi, Russell J Schilder, Lainie P Martin, et al.
Molecular Cancer Therapeutics|August 1, 2015
Targeting c-MYC in Platinum-Resistant Ovarian CancerJeyshka M Reyes-González, Guillermo N Armaiz-Peña, Lingegowda S Mangala, et al.
Molecular Cancer Therapeutics|January 15, 2015
Efficacy of Hedgehog pathway inhibitors in Basal cell carcinomaNicole Basset-Seguin, Hayley J Sharpe, Frederic J de Sauvage
Molecular Cancer Therapeutics|January 16, 2015
CD30 is a potential therapeutic target in malignant mesotheliomaSnehal Dabir, Adam Kresak, Michael Yang, et al.
Molecular Cancer Therapeutics|December 11, 2014
Midkine lacking its last 40 amino acids acts on endothelial and neuroblastoma tumor cells and inhibits tumor developmentNoushin Dianat, Barbara Le Viet, Emilie Gobbo, et al.
Pageof 599